Eva Pharma Launches Affordable Diabetes Medications in Nigeria 

Pictures of The Event. Photo credit : Eva Pharma

Eva Pharma, a leading pharmaceutical company, has introduced a new range of diabetes medications in Nigeria, promising top-quality healthcare solutions at pocket-friendly prices. 

New Medications to Manage Diabetes and Its Complications 

At a recent event in Lagos, Eva Pharma unveiled three key medications: 

    Gliptus Plus: Helps manage blood sugar levels for diabetes patients. 

    Thiotacid: Treats nerve damage caused by diabetes (diabetic neuropathy). 

    Donifoxate: Used for managing gout and high uric acid levels. 

These medications aim to address diabetes and related health conditions while making treatment more accessible for Nigerians. 

Commitment to Affordable Healthcare 

Bishoy Faltas, Eva Pharma’s Head of Marketing for West Africa, expressed pride in the company’s entry into the Nigerian market. He emphasized the firm’s mission to close the gap in quality healthcare access. We designed our products to be affordable while maintaining the same high standards as those used in Europe, Asia, and North America,” Faltas said. He highlighted that Eva Pharma understands Nigeria’s economic challenges and has created a strategy to keep medication prices low without compromising quality. 

Supporting Nigerian Patients 

David Otokpa, Eva Pharma’s Country Head for Nigeria, stressed the company’s focus on patient welfare rather than profits. He explained that many Nigerians face tough choices between feeding their families and buying medicines. Our goal is to provide affordable, high-quality medications that everyone can access,” Otokpa said. He also acknowledged that economic realities like inflation and low income have made healthcare unaffordable for many Nigerians. 

Expert Insights on Diabetes Management 

Medical experts at the event shared valuable insights into managing diabetes. 

    Dr. Bolanle Okunowo, a clinical endocrinologist, spoke about the high rate of undiagnosed diabetes in Nigeria. 

    Other experts, including Dr. Israel Akinmokan and Professor Olufemi Fasanmade, discussed the benefits of medications like Alpha Lipoic Acid for treating diabetes-related nerve damage. 

Building Partnerships for Better Healthcare 

Eva Pharma also announced key partnerships with global pharmaceutical giants: 

    An agreement with Gilead to distribute Lenacapavir API. 

    A deal with Eli Lilly to manufacture insulin for diabetes patients. 

Healthcare should not be a luxury; our mission is to provide high-quality, affordable medications that every Nigerian can access.” 

A Patient-Centered Approach 

Eva Pharma’s entry into Nigeria comes at a time when some multinational pharmaceutical companies, like GlaxoSmithKline and Sanofi Aventis, have scaled back their operations in the country due to economic difficulties. By focusing on affordability and quality, Eva Pharma hopes to ease the healthcare burden for Nigerians and ensure life-saving medications are within reach for all. Healthcare should not be a luxury,” Faltas concluded. “It is our mission to serve as many patients as possible by providing affordable and reliable solutions. 

Eva Pharma’s introduction of affordable diabetes medications is a significant step toward improving healthcare access for Nigerians. By prioritizing quality and affordability, the company is addressing the challenges many faces in managing chronic illnesses. Through partnerships with global pharmaceutical leaders and a patient-centered approach, Eva Pharma is making life-saving treatments more accessible to Nigerians. This initiative offers hope to patients and sets a new standard for affordable healthcare in the country.